KMD Bioscience has dedicated years to research in the antibody field. Obtaining effective and stable recombinant antibodies is fundamental and critical to antibody drug development. KMD Bioscience has established a comprehensive Phage Display Technology Platform capable of preparing recombinant monoclonal antibodies from various species, including rabbit, mouse, alpaca, and ovine. Our antibody team possesses proficient technical expertise in in vitro diagnostics and antibody/antigen R&D, with extensive experience in antibody selection and characterization, ensuring the delivery of high-quality recombinant antibodies.
Rat monoclonal antibodies typically exhibit minimal background cross-reactivity and offer advantages such as low cost and convenient production. KMD Bioscience can produce rat monoclonal antibodies with high specificity, high activity, and high affinity for clients within a relatively short turnround time. Utilizing our phage display technology platform, rat antibody genes are cloned into phagemid vectors, enabling scalable rat monoclonal antibody production when combined with various protein expression techniques.
We provide clients with one-stop Customized Antibody Services, encompassing peptide immunogen design and synthesis, protein recombinant expression, animal immunization, hybridoma preparation, and antibody purification. We also offer a series of downstream antibody validation and related services to meet diverse client requirements.
0
